Document Detail


A dose-finding study of azithromycin in the treatment of acne vulgaris.
MedLine Citation:
PMID:  17868539     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This open, multicenter, comparative, randomized study included 120 subjects with papulopustular stage of acne vulgaris. Subjects were randomized to one of the three treatment groups (A, total dose 4.5 g of azithromycin in 7 weeks; B, total dose 6.0 g in 10 weeks; and C, total dose 7.5 g in 13 weeks). The aim was to identify the optimum azithromycin dose in the treatment of acne vulgaris through monitoring the efficacy and safety of three dosage regimens. Clinical efficacy was assessed upon completion of study therapy and six months of therapy initiation. Post-therapeutic efficacy assessment was available in 104 subjects. The difference between three treatment groups was most pronounced in the "cure" category (36.11% in group A, 58.82% in group B and 55.88% in group C) and "failure" category (8.33% in group A, and no failures in groups B and C). Follow up efficacy assessment was available in 87 subjects. The group percentage of "cure" was lower and group percentage of "treatment failure" higher in group A than in groups B and C. Azithromycin in a total dose of 6.0 g in 10 weeks seems to be a promising agent in the treatment of papulopustular acne vulgaris with few side effects and good patient compliance.
Authors:
Aleksandra Basta-Juzbasić; Jasna Lipozencić; Lenka Oremović; Lena Kotrulja; Franjo Gruber; Ines Brajac; Dujomir Marasović; Deny Andjelinović; Lidija Herceg-Harjacek; Livija Cvitković
Related Documents :
23265749 - Comparison of quadriceps-sparing minimally invasive and medial parapatellar total knee ...
23089349 - Tourniquet use does not affect rehabilitation, return to activities, and muscle damage ...
22334629 - Short- and mid-term safety and effectiveness of transcatheter aortic valve implantation...
1554839 - Failure of ceftriaxone in the treatment of acute brucellosis.
17633139 - A six-month audit of the isolation of fusobacterium necrophorum from patients with sore...
23276359 - Artificial disk replacement combined with midlevel acdf versus multilevel fusion for ce...
20598759 - Pulmonary valve replacement in chronic pulmonary regurgitation in adults with congenita...
3524119 - A comparative study on the antipsychotic properties of desenkephalin-gamma-endorphin an...
20854049 - Modification of copd presentation during the last 25 years.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Acta dermatovenerologica Croatica : ADC     Volume:  15     ISSN:  1330-027X     ISO Abbreviation:  Acta Dermatovenerol Croat     Publication Date:  2007  
Date Detail:
Created Date:  2007-09-17     Completed Date:  2008-01-10     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  9433781     Medline TA:  Acta Dermatovenerol Croat     Country:  Croatia    
Other Details:
Languages:  eng     Pagination:  141-7     Citation Subset:  IM    
Affiliation:
University Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine, Zagreb, Croatia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acne Vulgaris / drug therapy*
Adolescent
Adult
Anti-Bacterial Agents / administration & dosage*
Azithromycin / administration & dosage*
Dose-Response Relationship, Drug
Female
Humans
Male
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 83905-01-5/Azithromycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of Chlamydia trachomatis in prostatitis syndrome--our experience in diagnosis and treatment...
Next Document:  Axillary apocrine carcinoma associated with apocrine adenoma and apocrine gland hyperplasia.